Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Growth differentiation factor 15 in heart failure with preserved vs. reduced ejection fraction
Michelle Chan, Rajalakshmi Santhanakrishnan, Jenny Chong, et al.
European Journal of Heart Failure (2015) Vol. 18, Iss. 1, pp. 81-88
Open Access | Times Cited: 151

Showing 26-50 of 151 citing articles:

Biomarkers, myocardial fibrosis and co-morbidities in heart failure with preserved ejection fraction: an overview
Marta Michalska, Agata Bielecka‐Dąbrowa, Stephan von Haehling, et al.
Archives of Medical Science (2018) Vol. 14, Iss. 4, pp. 890-909
Open Access | Times Cited: 54
The difference in referencing in Web of Science, Scopus, and Google Scholar
Markus S. Anker, Sara Hadzibegovic, Alessia Lena, et al.
ESC Heart Failure (2019) Vol. 6, Iss. 6, pp. 1291-1312
Open Access | Times Cited: 54
Cardioprotective actions of relaxin
Brian Martin, Guillermo Romero, Guy Salama
Molecular and Cellular Endocrinology (2019) Vol. 487, pp. 45-53
Open Access | Times Cited: 52
Prognostication in Different Heart Failure Phenotypes: The Role of Circulating Biomarkers
Alexander Е. Berezin
Journal of Circulating Biomarkers (2016) Vol. 5, pp. 6-6
Open Access | Times Cited: 48
Beyond Natriuretic Peptides for Diagnosis and Management of Heart Failure
Nasrien E. Ibrahim, James L. Januzzi
Clinical Chemistry (2016) Vol. 63, Iss. 1, pp. 211-222
Open Access | Times Cited: 48
Mechanisms, diagnosis, and treatment of heart failure with preserved ejection fraction and diastolic dysfunction
Gilman Plitt, Jordan T. Spring, Michael J. Moulton, et al.
Expert Review of Cardiovascular Therapy (2018) Vol. 16, Iss. 8, pp. 579-589
Open Access | Times Cited: 47
The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure
Bernadet T. Santema, Michelle Chan, Jasper Tromp, et al.
Clinical Research in Cardiology (2019) Vol. 109, Iss. 3, pp. 331-338
Open Access | Times Cited: 43
GDF-15 como Biomarcador em Doenças Cardiovasculares
Bruna Miers May, Maurício Pimentel, Leandro Ioschpe Zimerman, et al.
Arquivos Brasileiros de Cardiologia (2021)
Open Access | Times Cited: 35
Growth differentiation factor-15, a novel systemic biomarker of oxidative stress, inflammation, and cellular aging: Potential role in cardiovascular diseases
Angelo Michele de Candia, Diane Xavier de Ávila, Gustavo Rodolfo Moreira, et al.
American Heart Journal Plus Cardiology Research and Practice (2021) Vol. 9, pp. 100046-100046
Open Access | Times Cited: 34
Prognostic value of natriuretic peptides in heart failure: systematic review and meta-analysis
Tayler A. Buchan, Crizza Ching, Farid Foroutan, et al.
Heart Failure Reviews (2021) Vol. 27, Iss. 2, pp. 645-654
Closed Access | Times Cited: 33
Multimarker Analysis of Serially Measured GDF-15, NT-proBNP, ST2, GAL-3, cTnI, Creatinine, and Prognosis in Acute Heart Failure
Muhammed T. Gürgöze, Laura C. van Vark, Sara J. Baart, et al.
Circulation Heart Failure (2022) Vol. 16, Iss. 1
Open Access | Times Cited: 27
Growth differentiation factor‐15 and the effect of empagliflozin in heart failure: Findings from the EMPEROR program
João Pedro Ferreira, Milton Packer, Javed Butler, et al.
European Journal of Heart Failure (2023) Vol. 26, Iss. 1, pp. 155-164
Open Access | Times Cited: 14
Relaxin reverses inflammatory and immune signals in aged hearts
Brian Martin, Beth A. Gabris-Weber, Rajiv P. Reddy, et al.
PLoS ONE (2018) Vol. 13, Iss. 1, pp. e0190935-e0190935
Open Access | Times Cited: 43
An Automated Assay for Growth Differentiation Factor 15
Kai C. Wollert, Tibor Kempf, Evangelos Giannitsis, et al.
The Journal of Applied Laboratory Medicine (2017) Vol. 1, Iss. 5, pp. 510-521
Open Access | Times Cited: 40
Reappraisal of Inflammatory Biomarkers in Heart Failure
Thanat Chaikijurajai, W.H. Wilson Tang
Current Heart Failure Reports (2020) Vol. 17, Iss. 1, pp. 9-19
Open Access | Times Cited: 36
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers
Michela Chianca, Giorgia Panichella, Iacopo Fabiani, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 20
Growth Differentiation Factor-15 (GDF-15) is a Biological Marker in Heart Failure
Amina M. Alieva, Е. В. Резник, Т. В. Пинчук, et al.
The Russian Archives of Internal Medicine (2023) Vol. 13, Iss. 1, pp. 14-23
Open Access | Times Cited: 11
Prognostic Value of Inflammatory Cytokines in Predicting Hospital Readmissions in Heart Failure with Preserved Ejection Fraction
Zhihao Zhao, Diya Qi, Zeqing Zhang, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 3003-3012
Open Access | Times Cited: 4
Role and prognostic value of growth differentiation factor 15 in patient of heart failure with preserved ejection fraction: insights from the PURSUIT-HFpEF registry
Daisuke Sakamoto, Yuki Matsuoka, Daisaku Nakatani, et al.
Open Heart (2025) Vol. 12, Iss. 1, pp. e003008-e003008
Open Access
Patients with chronic heart failure and predominant left atrial versus left ventricular myopathy
Xuanyi Jin, Wan Ting Tay, Dinna Soon, et al.
Cardiovascular Ultrasound (2025) Vol. 23, Iss. 1
Open Access
Growth differentiation factor‐15 and N‐terminal pro‐BNP in acute heart failure with preserved ejection fraction
Yoichiro Otaki, Tetsu Watanabe, Mari Shimizu, et al.
ESC Heart Failure (2025)
Open Access
Growth Differentiation Factor 15 Inhibits Cardiac Fibrosis, Oxidative Stress, Inflammation, and Apoptosis in a Rat Model of Heart Failure with Preserved Ejection Fraction
Xuyang Meng, Yi Li, Ling‐bing Meng, et al.
Frontiers in Bioscience-Landmark (2025) Vol. 30, Iss. 2
Open Access
Growth Differentiation Factor 15 Is Associated With Major Amputation and Mortality in Patients With Peripheral Artery Disease
Judith J. de Haan, Saskia Haitjema, Hester M. den Ruijter, et al.
Journal of the American Heart Association (2017) Vol. 6, Iss. 9
Open Access | Times Cited: 37
The Role of GDF-15 in Heart Failure Patients With Chronic Kidney Disease
Jan Beneš, Martin Kotrč, Peter Wohlfahrt, et al.
Canadian Journal of Cardiology (2018) Vol. 35, Iss. 4, pp. 462-470
Closed Access | Times Cited: 36
Towards a multi‐marker prognostic strategy in acute heart failure: a role for GDF‐15
Paulo Bettencourt, João Ferreira‐Coimbra, Pedro Rodrigues, et al.
ESC Heart Failure (2018) Vol. 5, Iss. 6, pp. 1017-1022
Open Access | Times Cited: 35

Scroll to top